We are live on ! Find out more
CCM

Compton Capital Management Portfolio holdings

AUM $4.32M
1-Year Est. Return 27.38%
This Fund
S&P 500
This Quarter Est. Return
-9.03%
1 Year Est. Return
+27.38%
3 Year Est. Return
+75.57%
5 Year Est. Return
+123.58%
10 Year Est. Return
+305.72%
AUM
$278M
AUM Growth
+$95.8M
Cap. Flow
-$2.91M
Cap. Flow %
-1.05%
Top 10 Hldgs %
61.72%
Holding
141
New
1
Increased
29
Reduced
66
Closed
9

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$511K
2
PGX icon
Invesco Preferred ETF
PGX
+$423K
3
VTRS icon
Viatris
VTRS
+$349K
4
MSFT icon
Microsoft
MSFT
+$320K
5
JNJ icon
Johnson & Johnson
JNJ
+$175K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$288K
2
APA icon
APA Corp
APA
+$281K
3
GILD icon
Gilead Sciences
GILD
+$264K
4
FLR icon
Fluor
FLR
+$252K
5
TWX
Time Warner Inc
TWX
+$237K

Sector Composition

Rank Sector Weight
1 Technology 51.09%
2 Healthcare 11.8%
3 Financials 8.47%
4 Industrials 6.59%
5 Communication Services 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APD icon
126
Air Products & Chemicals
APD
$68B
$216K 0.08%
1,829
– –
MRO
127
DELISTED
Marathon Oil Corporation
MRO
$215K 0.08%
13,955
-2,950
-17% -$56K
DD icon
128
DuPont de Nemours
DD
$18.7B
$210K 0.08%
1,960
– –
A icon
129
Agilent Technologies
A
$44.5B
$204K 0.07%
5,931
-150
-2% -$5.67K
FCX icon
130
Freeport-McMoran
FCX
$113B
$165K 0.06%
17,072
– –
RXII
131
DELISTED
GALENA BIOPHARMA INC COM
RXII
$24K 0.01%
15,000
– –
QMCO icon
132
Quantum Corp
QMCO
$928M
$14K 0.01%
125
– –
APA icon
133
APA Corp
APA
$14.8B
– –
-4,875
Closed -$281K
FLR icon
134
Fluor
FLR
$7.24B
– –
-4,750
Closed -$252K
GSK icon
135
GSK
GSK
$101B
– –
-4,155
Closed -$216K
OXY icon
136
Occidental Petroleum
OXY
$59.1B
– –
-2,629
Closed -$204K
TEVA icon
137
Teva Pharmaceuticals
TEVA
$43.8B
– –
-3,765
Closed -$222K
SCU
138
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
– –
-1,030
Closed -$126K
TWX
139
DELISTED
Time Warner Inc
TWX
– –
-2,707
Closed -$237K
MON
140
DELISTED
Monsanto Co
MON
– –
-1,950
Closed -$208K
BCS.PRC
141
DELISTED
BARCLAYS BK PLC SPONSORED ADS SER 4 PREF SHS (UK)
BCS.PRC
– –
-8,199
Closed -$212K
2 3 4 5
6

Similar funds

GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
SM
SG3 Management Dorado, Puerto Rico $6.45K AUM 61.81% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

Compton Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Compton Capital Management held 141 positions worth $278M, up 53% from $182M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Compton Capital Management's Q3 2015 filing shows 1 new, 29 increased, 66 reduced and 9 closed positions. Its largest new stake was Viatris: 6,255 shares worth $252K. The largest sale was AbbVie, an estimated $288K.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Compton Capital Management's largest Q3 2015 buy was Viatris: 6,255 shares worth $252K.
  • Compton Capital Management added most to Walt Disney in Q3 2015, an estimated $511K increase.
  • Compton Capital Management's biggest Q3 2015 reduction was AbbVie, cutting an estimated $288K.
  • Compton Capital Management fully exited APA Corp in Q3 2015, selling an estimated $281K.
  • Compton Capital Management's ten largest holdings make up 62% of its $278M portfolio in Q3 2015.
  • Compton Capital Management opened 1 new position and closed 9 in Q3 2015.
  • Compton Capital Management's portfolio value rose 53% quarter-over-quarter to $278M.

Based on Compton Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.